AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Fulgent Genetics' 15min chart shows KDJ Death Cross, Bearish Marubozu.
ByAinvest
Tuesday, Aug 19, 2025 1:52 pm ET1min read
Fulgent Genetics's 15-minute chart has triggered a KDJ Death Cross and a Bearish Marubozu at 08/19/2025 13:45, indicating a shift in momentum towards the downside and a potential for further decreases in stock price. Sellers are currently in control of the market, and the bearish momentum is likely to persist.
Fulgent Genetics' (NASDAQ: FLGT) 15-minute chart has triggered a significant technical signal, indicating a potential shift in the stock's momentum towards the downside. At 08/19/2025 13:45, the chart displayed a KDJ Death Cross and a Bearish Marubozu pattern, suggesting a bearish trend and further potential decreases in stock price.The KDJ Death Cross is a bearish technical indicator that signals a shift in the momentum of the stock price towards the downside. This pattern occurs when the K line crosses below the D line on the KDJ indicator, indicating a potential reversal in the stock's trend [1]. The Bearish Marubozu pattern, which appeared on August 19, 2025, at 13:45, further supports this bearish sentiment. This pattern is characterized by a single candle with no upper wick, indicating strong selling pressure and a potential downward trend [2].
Despite mixed financial performance reported in the second quarter of 2025, Fulgent Genetics raised its full-year core revenue guidance to $320 million, reflecting strong momentum in its laboratory services and therapeutic development businesses [3]. However, the technical analysis indicates a bearish trend, with the KDJ Death Cross and Bearish Marubozu signaling a downward momentum in the stock price [4].
Looking ahead, Fulgent Genetics has forecasted average revenue growth of 9.0% per annum over the next three years, compared to a 6.0% industry growth forecast for the U.S. healthcare sector [1]. However, the technical analysis suggests a bearish trend, with a KDJ Death Cross and a Bearish Marubozu signaling a downward momentum in the stock price [4].
References:
[1] https://finance.yahoo.com/news/fulgent-genetics-second-quarter-2025-131814335.html
[2] https://www.tipranks.com/news/company-announcements/fulgent-genetics-reports-q2-2025-financial-results
[3] https://www.marketbeat.com/instant-alerts/fulgent-genetics-nasdaqflgt-shares-gap-up-after-earnings-beat-2025-08-01/
[4] https://www.investing.com/news/transcripts/earnings-call-transcript-fulgent-genetics-q2-2025-exceeds-revenue-forecast-stock-surges-93CH-4166152
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet